Name: The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats (Video) | JoVE Journal
Uploaded: 2019-03-08T14:30:00.000+00:00
Duration: 7 min 29 s
Description: Learn the left pneumonectomy procedure in rats to model pulmonary arterial hypertension with plexiform lesions. This protocol enables therapeutic development for PAH and related cardiovascular conditions.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This manuscript was supported by NIH grant 7R01 HL083078-10 grants from the American Heart Association AHA-17SDG33370112 and from the National Institutes of Health NIH K01 HL135474 to Y.S. and from the National Institutes of Health R01 HL133554 to L.H.

The procedures described below have been approved by the Institutional Animal Care and Use Committee (IACUC) of the Icahn School of Medicine at Mount Sinai. All rats received humane care in compliance with the Mount Sinai &#8220;Guide for the Care and Use of Laboratory Animals&#8221;.
1. Preparation for Surgery
<ol>
	<li>Autoclave Cooley-Mayo curved scissors (large scissors), straight Iris scissors (small scissors), McPherson-Vannas Iris scissors (back scissors), Wangensteen tissue forceps (atraumatic forceps), Gerald tissue forceps, plain wire speculum (self-retaining retractor), small vessel cauterizer, gauze, double-ended probe, thin vascular needle holder, and Micro-Jacobson mosquito hemostatic forceps (mosquito).</li>
</ol>
2. Preparation and Intubation of Rats
<ol>
	<li>Administer a subcutaneous injection of buprenorphine analgesia (0.1 mg/kg) in 6&#8211;8 week old male, Sprague-Dawley rats, 30 min prior to surgery.</li>
	<li>Place the rat individually in a chamber exposed to isoflurane 4% and oxygen (1 L/min) for 3&#8211;4 min until the rat is properly anesthetized (i.e., unconscious, breathing slowly, and unresponsive to touch or sound).</li>
	<li>Intubation of Rats
	<ol>
		<li>Remove the rat from the chamber and tape the rat to a board so the rat lays flat on its back, with the mouth at the edge of the board. Use string to hold the rat by the two front teeth so that the neck remains flat/straight.</li>
		<li>Place a fiber optic goose light source above the neck over the larynx, lift and hold the tongue with fingers, and move the epiglottis up to visualize the vocal cords. The trachea should be brightly lit behind the vocal cords; adjust the position of the light until the trachea is bright.</li>
		<li>Intubate the rats by inserting a 16 G catheter into the larynx within 60 s&#160;of removing the rat from the chamber as they wake quickly. If the rat wakes before successful intubation, put the rat back and repeat.&#160;</li>
		<li>Immediately connect the rat to the ventilator to resume isoflurane and oxygen delivery. Confirm the intubation using a cold mirror to observe condensation of the humidity in the exhaled breath from the catheter. Make sure the animal is still breathing by the expansion of the chest.</li>
	</ol>
	</li>
	<li>Connect the rat to the ventilator. Set the oxygen to flow at 1 L/min. Set the ventilation rate to 70 breaths/min with a tidal volume of 0.35&#8211;0.45 mL. Set positive end expiratory pressure (PEEP) to 2&#8211;4 cm H2O. Reduce isoflurane to 2&#8211;3%.</li>
	<li>Place the rat under the microscope in the right decubitus position on a heating pad at 37 &#176;C. Tape the front legs down. Shave the left thorax behind the front leg until the end of the rib cage with clippers. Clean the surgical area with gauze and 10% povidone-iodine solution, followed by 70% ethanol (three times).</li>
	<li>Place the pulse oximeter on the rat&#8217;s foot and monitor the heart rate and oxygen saturation throughout the surgery. Heart rate should be between 200&#8211;500 bpm and oxygen saturation should be &#62;95%.</li>
</ol>
3. Preparation of Sterile Environment
<ol>
	<li>Visualize the surgical area under the microscope. This must be done first because the microscope cannot be adjusted once the environment is sterile.</li>
	<li>Put on sterile, surgical gloves. Do not touch anything besides the sterilized instruments, the surgical drapes, and the surgical area of the rat&#8217;s body.</li>
	<li>Place a sterile drape over the rat&#8217;s body and on the instrument tray to create a sterile environment.</li>
	<li>With sterile gloves, place sterile instruments on the sterile instrument tray.</li>
</ol>
4. Left Pneumonectomy Surgical Procedure
<ol>
	<li>Use Cooley-Mayo scissors and Gerald tissue forceps to cut a small hole in the surgical drape. The hole should be about 2&#8211;3 cm in diameter to fully visualize the incision but not too large so that only sterilized skin is exposed.</li>
	<li>Make a 2 cm long lateral incision in the left thorax using a surgical blade. Use gauze and the electrocautery pen to manage bleeding/maintain hemostasis. Use the Cooley-Mayo scissors to cut each layer of tissue until the ribs and intercostal muscles are exposed.</li>
	<li>Entering Intercostal Space
	<ol>
		<li>Use the mosquito to make a hole through the muscle of the third intercostal space.</li>
		<li>Use the double-ended probe to move the lung out of the way to visualize the pulmonary artery. The investigator may enter another intercostal space if the pulmonary artery is not accessible.</li>
		<li>Use iris scissors and McPherson-Vannas iris scissors (back scissors) to open the intercostal muscles to about 1&#8211;2 cm. Use the electrocautery pen to stop any bleeding.</li>
		<li>Place a small, self-retaining retractor to hold the ribs and muscles open.</li>
	</ol>
	</li>
	<li>Open only the left pleura and move the left lung down lower in the abdomen to allow access to the pulmonary artery and bronchus. Load a medium hemoclip into the ligating clip applicator.</li>
	<li>Ligation of the Left Main Bronchus and Left Main Pulmonary Artery
	<ol>
		<li>Lift the upper portion of the left lung carefully with the Wangensteen atraumatic forceps to expose the pulmonary artery.</li>
		<li>Clip the pulmonary artery by closing the clip and applicator around the artery. Be careful not to close or rupture the left azygos vein. Do not clamp too forcefully otherwise, the vessel can rupture.</li>
		<li>Open the incision further using the tonsil to separate the muscle fibers.</li>
		<li>Load another medium hemoclip into the ligating clip applicator so that it is ready.</li>
		<li>Use the atraumatic forceps to lift the lower portion of the lung out of the incision until the left main bronchus and left pulmonary vein are visualized. Atraumatic forceps must be used pull to move the lung up and out of the incision. Since the lung is too large to be pulled out in one motion without tearing the tissue, the issue forceps are necessary to hold the lung in place while the atraumatic forceps are used carefully to pull more lung out.</li>
		<li>Ligate the left main bronchus and left main pulmonary vein together by closing the applicator around them. Do not clamp the vein and bronchus too forcefully otherwise, the vessel can rupture.</li>
	</ol>
	</li>
	<li>Remove the lung with scissors. Be careful not to cut or tear out the clip. Use a small piece of sterile gauze to absorb any blood and make sure there is no bleeding.</li>
	<li>Closure of the Ribs and Intercostal Muscles
	<ol>
		<li>Before closing the intercostal muscles, insert a 16 G catheter into the thoracic cavity away from the surgical incision and into the seventh intercostal space. Make sure the investigator can visualize the needle so as not to puncture any vital organs or vessels.</li>
		<li>Immediately remove the needle, leaving the catheter in place. This will be used as a chest tube.</li>
		<li>Close the ribs and intercostal muscles with a 4-0 prolene suture.</li>
		<li>Close the skin and subcutaneous space with a running 5-0 suture (Table of Materials).</li>
		<li>Place a 5-0 suture (Table of Materials) into the skin and around the chest tube so when the chest tube is removed, the hole will be tied shut.</li>
	</ol>
	</li>
	<li>Evacuate the air from the pleural cavity with a 3 mL syringe through the catheter to regain the negative normal pressure in the thorax. Immediately clamp the catheter with a needle holder to prevent air from going back into the thoracic cavity. Quickly remove the catheter and tie the suture to close the hole.</li>
</ol>
5. Post-operative Recovery
<ol>
	<li>Place the animal in the sternal position. Turn off the isoflurane but continue giving the rat oxygen via endotracheal tube. Do not leave the animal unattended at any point until it has regained sufficient consciousness to ambulate and the animal is safely in its cage.</li>
	<li>Administer 2&#8211;3 mL of sterile lactated Ringer&#8217;s solution subcutaneously.</li>
	<li>Monitor the heart rate (&#8776;200&#8211;500 bpm), oxygen saturation (&#8805;95%), and animal color to confirm the animal is breathing well.</li>
	<li>When the animal starts making spontaneous breathing motions and neck movements and responds to physical stimuli (such as eyes widening, nose moving, and ears responding to sound), extubate the animal by pulling out the catheter and disconnect the ventilator.</li>
	<li>Return the animal to an empty cage, away from the company of other animals. The animal should be alone for at least 3 days.</li>
	<li>For pain control, administer 0.1 mg/kg of Buprenorphine subcutaneously every 12 h for 3 days.</li>
</ol>
6. Administration of &#8220;Second Hit&#8221; MCT or Sugen
<ol>
	<li>Administer 1 mL of MCT (60 mg/kg) or 1 mL of Sugen (25 mg/kg) via subcutaneous injection, 1 week after the surgery.</li>
</ol>
7. Terminal Harvest
<ol>
	<li>Seven weeks after MCT or Sugen administration, place the animal in a&#160;chamber with flowing oxygen (1 L/min) and 4% isoflurane.</li>
	<li>Connect the animal to the ventilator via nose cone. Keep oxygen flowing and lower the isoflurane to 2.5&#8211;3%. Lay the animal on his back and tape down all limbs.</li>
	<li>Shave the animal along the entire abdomen.</li>
	<li>Opening the Chest
	<ol>
		<li>Make an incision down the chest&#160;with a scalpel from the subclavian notch to the xyphoid.</li>
		<li>Use the tissue forceps to hold the xyphoid. Cut through the sternum with the Cooley-Mayo scissors until the heart and pulmonary artery are fully accessible. Use the electrocautery to stop the bleeding. Hold the ribs open with a retractor.</li>
	</ol>
	</li>
	<li>Identify the pulmonary artery. Adjust the orientation of the heart, if necessary, by adding gauze underneath. Use a 20 G IV catheter to puncture the pulmonary artery between the pulmonary valve and the bifurcation of the main pulmonary artery. Advance only the 20 G catheter into the artery and remove the needle. Advance the 1.2 Fr transonic pressure catheter into IV catheter that is in the pulmonary artery. Once the PA curve is steady, record the pressure for at least 10 s. Repeat these steps to record the pressure in the right ventricle.</li>
	<li>Remove the heart and lungs. Place pieces of the lung in formalin to be fixed in paraffin and stained with hematoxylin and eosin.</li>
</ol>

<ol><li>Leopold, J., Maron, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Molecular+Mechanisms+of+Pulmonary+Vascular+Remodeling+in+Pulmonary+Arterial+Hypertension%5BTitle%5D)+AND+%22International+Journal+of+Molecular+Sciences%22%5BJournal%5D)">Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.</a> International Journal of Molecular Sciences. 17 (5), 761(2016).</li>
<li>Gomez-Arroyo, J. G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+monocrotaline+model+of+pulmonary+hypertension+in+perspective%5BTitle%5D)+AND+%22American+Journal+of+Physiology-Lung+Cellular+and+Molecular+Physiology%22%5BJournal%5D)">The monocrotaline model of pulmonary hypertension in perspective.</a> American Journal of Physiology-Lung Cellular and Molecular Physiology. 302 (4), L363-L369 (2012).</li>
<li>van Albada, M. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+role+of+increased+pulmonary+blood+flow+in+pulmonary+arterial+hypertension%5BTitle%5D)+AND+%22European+Respiratory+Journal%22%5BJournal%5D)">The role of increased pulmonary blood flow in pulmonary arterial hypertension.</a> European Respiratory Journal. 26 (3), 487-493 (2005).</li>
<li>Dickinson, M. G., Bartelds, B., Borgdorff, M. A. J., Berger, R. M. F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+role+of+disturbed+blood+flow+in+the+development+of+pulmonary+arterial+hypertension%3A+lessons+from+preclinical+animal+models%5BTitle%5D)+AND+%22American+Journal+of+Physiology-Lung+Cellular+and+Molecular+Physiology%22%5BJournal%5D)">The role of disturbed blood flow in the development of pulmonary arterial hypertension: lessons from preclinical animal models.</a> American Journal of Physiology-Lung Cellular and Molecular Physiology. 305 (1), L1-L14 (2013).</li>
<li>Stenmark, K. R., Meyrick, B., Galie, N., Mooi, W. J., McMurtry, I. F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Animal+models+of+pulmonary+arterial+hypertension%3A+the+hope+for+etiological+discovery+and+pharmacological+cure%5BTitle%5D)+AND+%22American+Journal+of+Physiology-Lung+Cellular+and+Molecular+Physiology%22%5BJournal%5D)">Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure.</a> American Journal of Physiology-Lung Cellular and Molecular Physiology. 297 (6), L1013-L1032 (2009).</li>
<li>Cahill, E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+pathophysiological+basis+of+chronic+hypoxic+pulmonary+hypertension+in+the+mouse%3A+vasoconstrictor+and+structural+mechanisms+contribute+equally%5BTitle%5D)+AND+%22Experimental+Physiology%22%5BJournal%5D)">The pathophysiological basis of chronic hypoxic pulmonary hypertension in the mouse: vasoconstrictor and structural mechanisms contribute equally.</a> Experimental Physiology. 97 (6), 796-806 (2012).</li>
<li>Okada, K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Pulmonary+hemodynamics+modify+the+rat+pulmonary+artery+response+to+injury.+A+neointimal+model+of+pulmonary+hypertension%5BTitle%5D)+AND+%22American+Journal+of+Pathology%22%5BJournal%5D)">Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension.</a> American Journal of Pathology. 151 (4), 1019-1025 (1997).</li>
<li>Happé, C. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Pneumonectomy+combined+with+SU5416+induces+severe+pulmonary+hypertension+in+rats%5BTitle%5D)+AND+%22American+Journal+of+Physiology-Lung+Cellular+and+Molecular+Physiology%22%5BJournal%5D)">Pneumonectomy combined with SU5416 induces severe pulmonary hypertension in rats.</a> American Journal of Physiology-Lung Cellular and Molecular Physiology. 310 (11), L1088-L1097 (2016).</li>
<li>Tanaka, Y., Schuster, D. P., Davis, E. C., Patterson, G. A., Botney, M. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+role+of+vascular+injury+and+hemodynamics+in+rat+pulmonary+artery+remodeling%5BTitle%5D)+AND+%22Journal+of+Clinical+Investigation%22%5BJournal%5D)">The role of vascular injury and hemodynamics in rat pulmonary artery remodeling.</a> Journal of Clinical Investigation. 98 (2), 434-442 (1996).</li>
<li>Nishimura, T., Faul, J. L., Berry, G. J., Kao, P. N., Pearl, R. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Effect+of+a+surgical+aortocaval+fistula+on+monocrotaline-induced+pulmonary+hypertension%5BTitle%5D)+AND+%22Critical+Care+Medicine%22%5BJournal%5D)">Effect of a surgical aortocaval fistula on monocrotaline-induced pulmonary hypertension.</a> Critical Care Medicine. 31 (4), 1213-1218 (2003).</li>
<li>Linardi, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Ventricular+and+pulmonary+vascular+remodeling+induced+by+pulmonary+overflow+in+a+chronic+model+of+pretricuspid+shunt%5BTitle%5D)+AND+%22Journal+of+Thoracic+and+Cardiovascular+Surgery%22%5BJournal%5D)">Ventricular and pulmonary vascular remodeling induced by pulmonary overflow in a chronic model of pretricuspid shunt.</a> Journal of Thoracic and Cardiovascular Surgery. 148 (6), 2609-2617 (2014).</li>
<li>White, R. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Plexiform-like+lesions+and+increased+tissue+factor+expression+in+a+rat+model+of+severe+pulmonary+arterial+hypertension%5BTitle%5D)+AND+%22American+Journal+of+Physiology-Lung+Cellular+and+Molecular+Physiology%22%5BJournal%5D)">Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension.</a> American Journal of Physiology-Lung Cellular and Molecular Physiology. 293 (3), L583-L590 (2007).</li>
<li>Samson, N., Paulin, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Epigenetics%2C+inflammation+and+metabolism+in+right+heart+failure+associated+with+pulmonary+hypertension%5BTitle%5D)+AND+%22Pulmonary+Circulation%22%5BJournal%5D)">Epigenetics, inflammation and metabolism in right heart failure associated with pulmonary hypertension.</a> Pulmonary Circulation. 7 (3), 572-587 (2017).</li>
</ol>

The authors have no potential conflicts of interest.

In PAH-affected lungs, vascular proliferation with neointimal formation and obliteration of the pulmonary arteries result in severe hemodynamic changes, right ventricular failure and early mortality7,8. The changes to the vessel walls increase resistance to blood flow, increasing arterial and right ventricular pressure. In the early stages of PAH, usually 3 weeks after administering MCT or Sugen, rats developed nonspecific histological changes like medial hypertr...

Pulmonary arterial hypertension (PAH) is a progressive and fatal disease characterized by an increase in pulmonary blood flow, increased vascular resistance, inflammation, and remodeling of small pulmonary blood vessels1. This remodeling usually results in vascular lesions that obstruct and obliterate small pulmonary arteries, causing vasoconstriction and increasing right ventricle afterload2. Few successful pharmacological treatments of PAH exist; as a consequence, PAH-related mortality remains high. Recently, the focus of research on the pathobiology of pulmonary hypertension has moved towards a mechanism of angio-proliferation in which the role of increased pulmonary blood flow is considered as an important trigger in the development of pulmonary vascular remodeling3,4.
Animal models of pulmonary hypertension have provided critical insights that help to explain the pathophysiology of the disease and have served as a platform for drug, cell, gene, and protein delivery. Traditionally, the chronic hypoxia-induced pulmonary hypertension model and the MCT lung injury model have been the main models used to study PAH pathophysiology5. However, they are not sufficient to produce increased pulmonary blood flow and neointimal pattern of remodeling compared to alterations described in human patients. The chronic-hypoxia model in rodents results in thickening of vessel walls with hypoxic vasoconstriction without angio-obliteration of small pulmonary vessels6. Additionally, the hypoxia condition is reversible. Thus, the hypoxia model is also not sufficient to produce severe PAH. The MCT lung injury model does elicit some endothelial dysfunction but the complex vascular obliterative lesions found in humans with severe primary PAH do not develop in the rats2. Additionally, MCT-treated rats tend to die from MCT-induced lung toxicity, veno-occlusive liver disease and myocarditis rather than from PAH2. Finally, the pneumonectomy alone is not sufficient to produce neointimal lesions in the small pulmonary vessels in a short period of time. After the pneumonectomy, there is minimal elevation in pulmonary arterial pressure7. In humans, the pneumonectomy is well tolerated when the contralateral lung is healthy7.
However, the left pneumonectomy procedure combined with MCT or Sugen is advantageous since it mimics increased pulmonary blood flow and results in pulmonary vascular remodeling comparable to severe clinical PAH. The pneumonectomy is performed on the left lung, which has only 1 lobe, rather than on the right, which has four lobes. If the right lung was removed, the animal would be unable to compensate for the respiratory insufficiency. In the pneumonectomy-MCT model, neointimal pattern of remodeling develops in over 90% of operated-animals treated7. Similarly, the combination of Sugen and pneumonectomy results in severe PAH, characterized by angio-obliterative vascular lesions, proliferation, apoptosis, and RV dysfunction8. The left pneumonectomy procedure is also advantageous compared to other surgical procedures to induce PAH. Previously described models in rats to increase pulmonary blood flow to the lungs include the aorto-caval shunt or subclavian-pulmonary artery anastomosis. These models are extremely complicated7,9,10,11. To perform an aorto-caval shunt, the animal&#39;s abdomen has to be opened. The shunt is placed in the abdominal aorta, which increases blood flow to all abdominal organs instead of just the lungs, thus, PAH takes much longer to develop. Additionally, it is difficult to determine the blood flow through the shunt, whereas with the pneumonectomy the blood flow to the remaining lung doubles. The subclavian-pulmonary artery anastomosis also has many complications. The flow of arterial blood into the vein can lead to thrombosis of anastomosis and bleeding. Like the aorto-caval shunt, it is difficult to determine the blood flow through the anastomosis. Furthermore, it is an expensive and difficult technique that requires vascular surgical skills. The unilateral left pneumonectomy doubles blood flow and shear stress in the contralateral lung and, in combination with MCT or Sugen, causes the typical hemodynamic and histopathological findings of PAH which is endothelial cell damage8,12.
The novelty of this manuscript is presented in the very detailed and comprehensive surgical protocol of the left pneumonectomy in rats and in the discussion of the technical and physiological challenges of these models. Because this protocol is not currently available, many investigators believe the model is too difficult use. Investigators who have performed the left pneumonectomy have faced high mortality and morbidity rates associated with the unnecessary loss of animals, compromising scientific assessment. Instead, many will use classical models such as MCT injection, chronic-hypoxia, or just the pneumonectomy to create PAH. However, these models are much less effective than the combination of MCT or Sugen with the left pneumonectomy. The primary purpose of this article is to provide the first detailed and reproducible surgical protocol for the left unilateral pneumonectomy in rats and provide the best surgical model of PAH. Combining this protocol for left unilateral pneumonectomy with MCT or SU5416 will allow investigators to create a far more effective and clinically relevant model of severe PAH to study the pathogenesis of this fatal disease.

<table><tbody><tr><td>Surgical Blade</td><td>Bard-Parker</td><td>371215</td><td>Incision</td></tr><tr><td>Forane (Isoflurane, USP)</td><td>Baxter</td><td>NDC 10019-360-40</td><td>anesthesia</td></tr><tr><td>BD Angiocath 16 G</td><td>BD</td><td>381157</td><td>intubation tube, chest tube</td></tr><tr><td>BD 1 mL Insulin Syringe</td><td>BD</td><td>329652</td><td>administer buprinex post-operatively</td></tr><tr><td>Biogel Surgeons Surgical Gloves</td><td>Biogel</td><td>30460-01</td><td>sterile surgical gloves</td></tr><tr><td>Wahl BravMini+ Trimmer</td><td>Braintree Scientific</td><td>CLP-41590 P</td><td>shave surgical site</td></tr><tr><td>SU5416</td><td>Cayman Chemical</td><td>13342</td><td>Sugen&amp;nbsp;</td></tr><tr><td>Fiber Optic Illuminator</td><td>Cole-Parmer</td><td>EW-41723-02</td><td>light for intubation</td></tr><tr><td>Surgipro II 4-0 Suture</td><td>Covidien</td><td>VP831X</td><td>Closing intercostal muscles</td></tr><tr><td>Polysorb 5-0 Suture</td><td>Covidien</td><td>GL-885</td><td>Closing skin</td></tr><tr><td>Medium Slide Top Induction Chamber</td><td>DRE Veterinary</td><td>12570</td><td>oxygen &amp;amp; isoflurane delivery</td></tr><tr><td>DRE Compact 150 Rodent Anesthesia Machine</td><td>DRE Veterinary</td><td>373</td><td>oxygen &amp;amp; isoflurane delivery</td></tr><tr><td>Small Vessel Cauterizer Kit</td><td>Fine Science Tools</td><td>18000-00</td><td>cauterizer to minimize bleeding</td></tr><tr><td>VentElite Small Animal Ventilator</td><td>Harvard Apparatus</td><td>55-7040</td><td>ventilator</td></tr><tr><td>MouseSTAT Jr</td><td>Kent Scientific</td><td>MSTAT-JR</td><td>pulse oximeter &amp;amp; heart rate monitor</td></tr><tr><td>Mouse Paw Pulse Oximeter Sensor</td><td>Kent Scientific</td><td>SPO2-MSE</td><td>pulse oximeter &amp;amp; heart rate paw sensor</td></tr><tr><td>PhysioSuite RightTemp</td><td>Kent Scientific</td><td>PS-02</td><td>temperature pad</td></tr><tr><td>PVP Prep Solution</td><td>Medline</td><td>MDS093944</td><td>Cleaning surgical site</td></tr><tr><td>Poly-lined Drape</td><td>Medline</td><td>NON21002Z</td><td>cover animal</td></tr><tr><td>3 mL syringe</td><td>Medline</td><td>SYR103010</td><td>administer fluids post-operatively</td></tr><tr><td>Microsurgical Kits, Integra&amp;nbsp;</td><td>Miltex</td><td>95042-540</td><td>surgical tools: plain wire speculum, double-ended probe, McPherson-Vannas Iris scissors straight, straight iris scissors</td></tr><tr><td>Hemostatic forceps - Micro-Jacobson-Mosquito</td><td>Miltex</td><td>17-2602</td><td>mosquito</td></tr><tr><td>Buprenorphrine HCl 0.3 mg/mL</td><td>Par Pharmaceutical</td><td>NDC 42023-179-01</td><td>Pain relief</td></tr><tr><td>Cooley-Mayo curved scissors</td><td>Pilling</td><td>352090</td><td>Large scissors</td></tr><tr><td>Gerald Tissue forceps</td><td>Pilling</td><td>351900</td><td>forceps</td></tr><tr><td>Wangesnsteen Tissue Forceps</td><td>Pilling</td><td>342929</td><td>atraumatic forceps</td></tr><tr><td>Pilling Thin Vascular Needle Holder</td><td>Pilling</td><td>354962DG</td><td>needle holder</td></tr><tr><td>Crotaline</td><td>Sigma-Aldrich</td><td>C2401-1G</td><td>MCT</td></tr><tr><td>Surflash 20 G IV Catheter</td><td>Terumo</td><td>SR*FF2051</td><td>For pressure reading during organ harvest</td></tr><tr><td>ADVantage PV System with 1.2 Fr Catheter</td><td>Transonic Inc</td><td>ADV500</td><td>Record pulmonary artery and right ventricle pressure</td></tr><tr><td>Medium Hemoclip</td><td>Weck</td><td>523700</td><td>ligate vessels</td></tr><tr><td>Open Ligating Clip Applicator; Medium, curved</td><td>Weck Horizon</td><td>237081</td><td>hemoclip applicator</td></tr><tr><td>Surgical Microscope</td><td>Zeiss OPMI MD</td><td>1808</td><td>magnification</td></tr></tbody></table>

the left pneumonectomy combined with monocrotaline or sugen as a model of pulmonary hypertension in rats

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

In this protocol, we detail the correct procedural steps and necessary precautions to successfully perform a left pneumonectomy and induce PAH in rats with the additional administration of monocrotaline (MCT) or SU5416 (Sugen). We also compare these two models to other PAH models commonly used in research. In the last few years, the focus of animal PAH models has moved towards studying the mechanism of angioproliferation of plexiform lesions, in which the role of increased pulmonary blood flow is considered as an important trigger in the development of severe pulmonary vascular remodeling. One of the most promising rodent models of increased pulmonary flow is the unilateral left pneumonectomy combined with a "second hit" of MCT or Sugen. The removal of the left lung leads to increased and turbulent pulmonary blood flow and vascular remodeling. Currently, there is no detailed procedure of the pneumonectomy surgery in rats. This article details a step-by-step protocol of the pneumonectomy surgical procedure and post-operative care in male Sprague-Dawley rats. Briefly, the animal is anesthetized and the chest is opened. Once the left pulmonary artery, pulmonary vein, and bronchus are visualized, they are ligated and the left lung is removed. The chest then closed and the animal recovered. Blood is forced to circulate only on the right lung. This increased vascular pressure leads to a progressive remodeling and occlusion of small pulmonary arteries. The second hit of MCT or Sugen is used one week post-surgery to induce endothelial dysfunction. The combination of increased blood flow in the lung and endothelial dysfunction produces severe PAH. The primary limitation of this procedure is that it requires general surgical skills.

According to the accepted classification system, pulmonary hypertension is characterized by a mean pulmonary artery pressure (mPAP) exceeding the upper limits of normal pulmonary artery pressure (i.e., 25 mm Hg). In the pneumonectomy + MCT group, severe PAH developed by day 21 with an increased mPAP (Figure 1). The mPAP is calculated by the formula:
<img alt="Pulmonary artery pressure calculation eq...

The rodent left pneumonectomy is a valuable technique in pulmonary hypertension research. Here, we present a protocol to describe the rat pneumonectomy procedure and postoperative care to ensure minimal morbidity and mortality.

In this protocol, we detail the correct procedural steps and necessary precautions to successfully perform a left pneumonectomy and induce PAH in rats ...

the-left-pneumonectomy-combined-with-monocrotaline-or-sugen-as-model

Research

JoVE Journal

Medicine

Pulmonary arterial hypertension (PAH) is a disease of pulmonary arterioles that leads to their obliteration and the development of right ventricular failure. Rodent models of PAH are critical in understanding the pathophysiology of PAH. Here we demonstrate hemodynamic characterization, with right heart catheterization and echocardiography, in the mouse and rat.

Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension

This protocol describes a surgical procedure to create a model for flow-induced pulmonary arterial hypertension (PAH) in rats and the procedures to analyze the principle hemodynamic and histological end-points in this model.

Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension

We present a surgical method to induce right ventricular hypertrophy and failure in rats.

A Pulmonary Trunk Banding Model of Pressure Overload Induced Right Ventricular Hypertrophy and Failure

Here, we present a protocol for an ex vivo lung cancer model that mimics the steps of tumor progression and helps to isolate a primary tumor, circulating tumor cells, and metastatic lesions.

Acellular and Cellular Lung Model to Study Tumor Metastasis

Left atrial stenosis (LAS) is a novel surgical technique used for studying group 2 pulmonary hypertension (PH) and mechanisms underlying pulmonary venous arterialization. Here, we present a protocol to constrict the left atrium using a titanium clip to cause pulmonary venous arterialization and moderate PH in a rat.

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat

This protocol describes the induction of pulmonary hypertension (PH) in mice based on the exposure to hypoxia and the injection of a VEGF receptor antagonist. The animals develop PH and right ventricular (RV) hypertrophy 3 weeks after the initiation of the protocol. The functional and morphometrical characterization of the model is also presented.

Induction and Characterization of Pulmonary Hypertension in Mice using the Hypoxia/SU5416 Model

Here, we present optimizations to a rat lung transplantation model that serve to improve outcomes. We provide a size guide for cuffs based on body weight, a measurement strategy to ascertain the 4th intercostal space, and methods of wound closure and BAL (bronchoalveolar lavage) fluid and tissue collection.

A Rat Lung Transplantation Model of Warm Ischemia/Reperfusion Injury: Optimizations to Improve Outcomes

Right heart failure (RHF) is characterized by right-sided cardiac dilation and hypertrophy, leading to ventricular and atrial malfunction. Cardiopulmonary conditions associated with RHF are accompanied by an increased risk for cardiac arrhythmias. This article describes a standardized model of pulmonary artery banding-induced RHF associated with enhanced ventricular and atrial arrhythmogenesis.

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Here, the method of inducing pulmonary arterial hypertension associated with pulmonary fibrosis (PF-PH) rat model by injecting bleomycin into the airway is introduced. We also provide a step-by-step approach to validate this animal model.

Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis

This protocol describes an improved technique for orthotopic left lung transplantation in rats, focusing on reducing operational difficulty and improving survival rates.

Orthotopic Left Lung Transplantation in Rats

Learn the left pneumonectomy procedure in rats to model pulmonary arterial hypertension with plexiform lesions. This protocol enables therapeutic development for PAH and related cardiovascular conditions.

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Explore More Videos